Donald A. Kalkofen - Net Worth and Insider Trading
Donald A. Kalkofen Net Worth
The estimated net worth of Donald A. Kalkofen is at least $34,439 dollars as of 2024-06-05. Donald A. Kalkofen is the CFO of Protagonist Therapeutics Inc and owns about 1,175 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $34,439. Details can be seen in Donald A. Kalkofen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald A. Kalkofen has not made any transactions after 2019-12-03 and currently still holds the listed stock(s).
Transaction Summary of Donald A. Kalkofen
Donald A. Kalkofen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Donald A. Kalkofen owns 1 companies in total, including Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Donald A. Kalkofen’s form 4 insider trades.
Insider Ownership Summary of Donald A. Kalkofen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2022-02-15 | Chief Financial Officer |
Donald A. Kalkofen Latest Holdings Summary
Donald A. Kalkofen currently owns a total of 1 stock. Donald A. Kalkofen owns 1,175 shares of Protagonist Therapeutics Inc (PTGX) as of December 3, 2019, with a value of $34,439.
Latest Holdings of Donald A. Kalkofen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2019-12-03 | 1,175 | 29.31 | 34,439 |
Holding Weightings of Donald A. Kalkofen
Donald A. Kalkofen Form 4 Trading Tracker
According to the SEC Form 4 filings, Donald A. Kalkofen has made a total of 1 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Protagonist Therapeutics Inc is the acquisition of 1,175 shares on December 3, 2019, which cost Donald A. Kalkofen around $5,993.
Insider Trading History of Donald A. Kalkofen
- 1
Donald A. Kalkofen Trading Performance
GuruFocus tracks the stock performance after each of Donald A. Kalkofen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald A. Kalkofen is 70.15%. GuruFocus also compares Donald A. Kalkofen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald A. Kalkofen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Donald A. Kalkofen's insider trading performs compared to the benchmark.
Performance of Donald A. Kalkofen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.51 | | | | | |
| Relative Return to S&P 500(%) | 35.93 | | | | | |
Donald A. Kalkofen Ownership Network
Donald A. Kalkofen Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Donald A. Kalkofen is the Chief Financial Officer of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , director & President and CEO Patel Dinesh V Ph D , and Chief Development Officer Suneel Gupta .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Donald A. Kalkofen made no insider transaction in Protagonist Therapeutics Inc (PTGX). Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 130,000 shares made by Patel Dinesh V Ph D , a net sale of 25,421 shares made by Asif Ali , and a net sale of 12,975 shares made by William D. Waddill .
In summary, during the past 3 months, insiders sold 26,234 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 26,234 shares. During the past 18 months, 175,244 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 175,244 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Donald A. Kalkofen Mailing Address
Above is the net worth, insider trading, and ownership report for Donald A. Kalkofen. You might contact Donald A. Kalkofen via mailing address: 7707 Gateway Boulevard, Suite 140, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
